Grant Sean's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Jun 16, 2022
- Accession no.
- 0001209191-22-037401
- Filed
- Jun 16, 2022
- Trade date
- Jun 15, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $68.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grant SeanCIK 0001872792 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2022 | Class A Common Stock | PPurchaseAcquired | +2,816 | $13.60F1 | +$38,297.6 | 2,816 | Indirect | |
| Jun 15, 2022 | Class A Common Stock | PPurchaseAcquired | +335 | $13.60F1 | +$4,556 | 335 | Indirect | |
| Jun 15, 2022 | Class A Common Stock | PPurchaseAcquired | +857 | $13.60F1 | +$11,655.2 | 857 | Indirect | |
| Jun 15, 2022 | Class A Common Stock | PPurchaseAcquired | +992 | $13.60F1 | +$13,491.2 | 992 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares were purchased in multiple transactions for all of Reporting Person's indirect accounts on the reported date with prices ranging from $13.05 to $13.85, resulting in a weighted average price of $13.6008. Upon request, the Reporting Person will provide to Issuer, the Commission staff or a security holder of the Issuer the number of shares purchased and the purchase price for each separate transaction.
Referenced by the price of 4 transactions in Table I.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney